_version_ 1782219607275208704
author Broen, Jasper CA
Bossini-Castillo, Lara
Bon, Lenny van
Vonk, Madelon C
Knaapen, Hanneke
Beretta, Lorenzo
Rueda, Blanca
Hesselstrand, Roger
Herrick, Ariane
Worthington, Jane
Hunzelmann, Nicholas
Denton, Christopher
Fonseca, Carmen
Riemekasten, Gabriela
Kiener, Hans
Scorza, Raffaella
Simeon, Carmen P
Ortego-Centeno, Norberto
Gonzalez-Gay, Miguel A
Airo’, Paolo
Coenen, Marieke JH
Martin, Javier
Radstake, Timothy RDJ
author_facet Broen, Jasper CA
Bossini-Castillo, Lara
Bon, Lenny van
Vonk, Madelon C
Knaapen, Hanneke
Beretta, Lorenzo
Rueda, Blanca
Hesselstrand, Roger
Herrick, Ariane
Worthington, Jane
Hunzelmann, Nicholas
Denton, Christopher
Fonseca, Carmen
Riemekasten, Gabriela
Kiener, Hans
Scorza, Raffaella
Simeon, Carmen P
Ortego-Centeno, Norberto
Gonzalez-Gay, Miguel A
Airo’, Paolo
Coenen, Marieke JH
Martin, Javier
Radstake, Timothy RDJ
author_sort Broen, Jasper CA
collection PubMed
description
format Online
Article
Text
id pubmed-3242230
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-32422302011-12-19 A rare polymorphism in Toll Like Receptor 2 is associated with systemic sclerosis phenotype and increases production of inflammatory mediators Broen, Jasper CA Bossini-Castillo, Lara Bon, Lenny van Vonk, Madelon C Knaapen, Hanneke Beretta, Lorenzo Rueda, Blanca Hesselstrand, Roger Herrick, Ariane Worthington, Jane Hunzelmann, Nicholas Denton, Christopher Fonseca, Carmen Riemekasten, Gabriela Kiener, Hans Scorza, Raffaella Simeon, Carmen P Ortego-Centeno, Norberto Gonzalez-Gay, Miguel A Airo’, Paolo Coenen, Marieke JH Martin, Javier Radstake, Timothy RDJ J Transl Med Oral Presentation BioMed Central 2011-11-23 /pmc/articles/PMC3242230/ http://dx.doi.org/10.1186/1479-5876-9-S2-O4 Text en Copyright ©2011 Broen et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Oral Presentation
Broen, Jasper CA
Bossini-Castillo, Lara
Bon, Lenny van
Vonk, Madelon C
Knaapen, Hanneke
Beretta, Lorenzo
Rueda, Blanca
Hesselstrand, Roger
Herrick, Ariane
Worthington, Jane
Hunzelmann, Nicholas
Denton, Christopher
Fonseca, Carmen
Riemekasten, Gabriela
Kiener, Hans
Scorza, Raffaella
Simeon, Carmen P
Ortego-Centeno, Norberto
Gonzalez-Gay, Miguel A
Airo’, Paolo
Coenen, Marieke JH
Martin, Javier
Radstake, Timothy RDJ
A rare polymorphism in Toll Like Receptor 2 is associated with systemic sclerosis phenotype and increases production of inflammatory mediators
title A rare polymorphism in Toll Like Receptor 2 is associated with systemic sclerosis phenotype and increases production of inflammatory mediators
title_full A rare polymorphism in Toll Like Receptor 2 is associated with systemic sclerosis phenotype and increases production of inflammatory mediators
title_fullStr A rare polymorphism in Toll Like Receptor 2 is associated with systemic sclerosis phenotype and increases production of inflammatory mediators
title_full_unstemmed A rare polymorphism in Toll Like Receptor 2 is associated with systemic sclerosis phenotype and increases production of inflammatory mediators
title_short A rare polymorphism in Toll Like Receptor 2 is associated with systemic sclerosis phenotype and increases production of inflammatory mediators
title_sort rare polymorphism in toll like receptor 2 is associated with systemic sclerosis phenotype and increases production of inflammatory mediators
topic Oral Presentation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3242230/
http://dx.doi.org/10.1186/1479-5876-9-S2-O4
work_keys_str_mv AT broenjasperca ararepolymorphismintolllikereceptor2isassociatedwithsystemicsclerosisphenotypeandincreasesproductionofinflammatorymediators
AT bossinicastillolara ararepolymorphismintolllikereceptor2isassociatedwithsystemicsclerosisphenotypeandincreasesproductionofinflammatorymediators
AT bonlennyvan ararepolymorphismintolllikereceptor2isassociatedwithsystemicsclerosisphenotypeandincreasesproductionofinflammatorymediators
AT vonkmadelonc ararepolymorphismintolllikereceptor2isassociatedwithsystemicsclerosisphenotypeandincreasesproductionofinflammatorymediators
AT knaapenhanneke ararepolymorphismintolllikereceptor2isassociatedwithsystemicsclerosisphenotypeandincreasesproductionofinflammatorymediators
AT berettalorenzo ararepolymorphismintolllikereceptor2isassociatedwithsystemicsclerosisphenotypeandincreasesproductionofinflammatorymediators
AT ruedablanca ararepolymorphismintolllikereceptor2isassociatedwithsystemicsclerosisphenotypeandincreasesproductionofinflammatorymediators
AT hesselstrandroger ararepolymorphismintolllikereceptor2isassociatedwithsystemicsclerosisphenotypeandincreasesproductionofinflammatorymediators
AT herrickariane ararepolymorphismintolllikereceptor2isassociatedwithsystemicsclerosisphenotypeandincreasesproductionofinflammatorymediators
AT worthingtonjane ararepolymorphismintolllikereceptor2isassociatedwithsystemicsclerosisphenotypeandincreasesproductionofinflammatorymediators
AT hunzelmannnicholas ararepolymorphismintolllikereceptor2isassociatedwithsystemicsclerosisphenotypeandincreasesproductionofinflammatorymediators
AT dentonchristopher ararepolymorphismintolllikereceptor2isassociatedwithsystemicsclerosisphenotypeandincreasesproductionofinflammatorymediators
AT fonsecacarmen ararepolymorphismintolllikereceptor2isassociatedwithsystemicsclerosisphenotypeandincreasesproductionofinflammatorymediators
AT riemekastengabriela ararepolymorphismintolllikereceptor2isassociatedwithsystemicsclerosisphenotypeandincreasesproductionofinflammatorymediators
AT kienerhans ararepolymorphismintolllikereceptor2isassociatedwithsystemicsclerosisphenotypeandincreasesproductionofinflammatorymediators
AT scorzaraffaella ararepolymorphismintolllikereceptor2isassociatedwithsystemicsclerosisphenotypeandincreasesproductionofinflammatorymediators
AT simeoncarmenp ararepolymorphismintolllikereceptor2isassociatedwithsystemicsclerosisphenotypeandincreasesproductionofinflammatorymediators
AT ortegocentenonorberto ararepolymorphismintolllikereceptor2isassociatedwithsystemicsclerosisphenotypeandincreasesproductionofinflammatorymediators
AT gonzalezgaymiguela ararepolymorphismintolllikereceptor2isassociatedwithsystemicsclerosisphenotypeandincreasesproductionofinflammatorymediators
AT airopaolo ararepolymorphismintolllikereceptor2isassociatedwithsystemicsclerosisphenotypeandincreasesproductionofinflammatorymediators
AT coenenmariekejh ararepolymorphismintolllikereceptor2isassociatedwithsystemicsclerosisphenotypeandincreasesproductionofinflammatorymediators
AT martinjavier ararepolymorphismintolllikereceptor2isassociatedwithsystemicsclerosisphenotypeandincreasesproductionofinflammatorymediators
AT radstaketimothyrdj ararepolymorphismintolllikereceptor2isassociatedwithsystemicsclerosisphenotypeandincreasesproductionofinflammatorymediators
AT broenjasperca rarepolymorphismintolllikereceptor2isassociatedwithsystemicsclerosisphenotypeandincreasesproductionofinflammatorymediators
AT bossinicastillolara rarepolymorphismintolllikereceptor2isassociatedwithsystemicsclerosisphenotypeandincreasesproductionofinflammatorymediators
AT bonlennyvan rarepolymorphismintolllikereceptor2isassociatedwithsystemicsclerosisphenotypeandincreasesproductionofinflammatorymediators
AT vonkmadelonc rarepolymorphismintolllikereceptor2isassociatedwithsystemicsclerosisphenotypeandincreasesproductionofinflammatorymediators
AT knaapenhanneke rarepolymorphismintolllikereceptor2isassociatedwithsystemicsclerosisphenotypeandincreasesproductionofinflammatorymediators
AT berettalorenzo rarepolymorphismintolllikereceptor2isassociatedwithsystemicsclerosisphenotypeandincreasesproductionofinflammatorymediators
AT ruedablanca rarepolymorphismintolllikereceptor2isassociatedwithsystemicsclerosisphenotypeandincreasesproductionofinflammatorymediators
AT hesselstrandroger rarepolymorphismintolllikereceptor2isassociatedwithsystemicsclerosisphenotypeandincreasesproductionofinflammatorymediators
AT herrickariane rarepolymorphismintolllikereceptor2isassociatedwithsystemicsclerosisphenotypeandincreasesproductionofinflammatorymediators
AT worthingtonjane rarepolymorphismintolllikereceptor2isassociatedwithsystemicsclerosisphenotypeandincreasesproductionofinflammatorymediators
AT hunzelmannnicholas rarepolymorphismintolllikereceptor2isassociatedwithsystemicsclerosisphenotypeandincreasesproductionofinflammatorymediators
AT dentonchristopher rarepolymorphismintolllikereceptor2isassociatedwithsystemicsclerosisphenotypeandincreasesproductionofinflammatorymediators
AT fonsecacarmen rarepolymorphismintolllikereceptor2isassociatedwithsystemicsclerosisphenotypeandincreasesproductionofinflammatorymediators
AT riemekastengabriela rarepolymorphismintolllikereceptor2isassociatedwithsystemicsclerosisphenotypeandincreasesproductionofinflammatorymediators
AT kienerhans rarepolymorphismintolllikereceptor2isassociatedwithsystemicsclerosisphenotypeandincreasesproductionofinflammatorymediators
AT scorzaraffaella rarepolymorphismintolllikereceptor2isassociatedwithsystemicsclerosisphenotypeandincreasesproductionofinflammatorymediators
AT simeoncarmenp rarepolymorphismintolllikereceptor2isassociatedwithsystemicsclerosisphenotypeandincreasesproductionofinflammatorymediators
AT ortegocentenonorberto rarepolymorphismintolllikereceptor2isassociatedwithsystemicsclerosisphenotypeandincreasesproductionofinflammatorymediators
AT gonzalezgaymiguela rarepolymorphismintolllikereceptor2isassociatedwithsystemicsclerosisphenotypeandincreasesproductionofinflammatorymediators
AT airopaolo rarepolymorphismintolllikereceptor2isassociatedwithsystemicsclerosisphenotypeandincreasesproductionofinflammatorymediators
AT coenenmariekejh rarepolymorphismintolllikereceptor2isassociatedwithsystemicsclerosisphenotypeandincreasesproductionofinflammatorymediators
AT martinjavier rarepolymorphismintolllikereceptor2isassociatedwithsystemicsclerosisphenotypeandincreasesproductionofinflammatorymediators
AT radstaketimothyrdj rarepolymorphismintolllikereceptor2isassociatedwithsystemicsclerosisphenotypeandincreasesproductionofinflammatorymediators